[“Candida Auris: Ignore it and Other Emerging Pathogens at Your Own Risk!” Registration for this event is FREE at: https://bit.ly/42lO4fG](https://wbbsec.com/press-releases/wbb-securities-will-be-sponsoring-a-demy-colton-virtual-salon-webinar-on-may-17-2023/)
[“Candida Auris: Ignore it and Other Emerging Pathogens at Your Own Risk!” Registration for this event is FREE at: https://bit.ly/42lO4fG](https://wbbsec.com/press-releases/wbb-securities-will-be-sponsoring-a-demy-colton-virtual-salon-webinar-on-may-17-2023/)
powered by bulletin

WHAT WE DO

WBB Securities is a leading Investment Management, Investment Banking, and Equity Research firm focused primarily on the life sciences niche. Established in 2001 with offices in New Jersey, New York, and California. WBB Securities is registered with the SEC as a broker-dealer, a member of the Financial Industry Regulatory Authority, and a state-registered investment advisor with a proprietary trading desk. The firm is comprised of a nationwide team of respected senior investment and research professionals serving institutional and high-net-worth clients.

Our investment bank has participated in over 250 transactions leading to $4 billion placed.  Whether raising capital or executing strategic transactions, our banking team is equipped to meet your financial needs and is comprised of some of the most knowledgeable people working in the life sciences domain.  Our firm has been distinguished from its peers for its equity research and analytics year after year for accuracy and performance by the financial industry’s most highly regarded rankings organizations.

Investment Management

Our Financial Advisors are skilled strategists and experts in financial planning, portfolio construction and investment management.

Equity Research

We cover the most dynamic life sciences companies in the industry, and are continuously recognized for research performance.

Institutional Sales

Our sales and trading professionals can assist you to meet all of your institutional equity sales requirements.

Investment Banking

Our investment banking practice is focused in the field of life sciences and is comprised of a team of the best specialists in the field.

M&A and Strategic Advisory

We have the relationships and analytics in place to power your M&A needs through our strategic transactions unit.

Equity Capital Markets

We offer a full spectrum of innovative products and services to meet your capital needs.

Press Releases

View All

  • Emerging pathogens are an increasing threat because most treatments for them are failing.

  • For Immediate Release February 20, 2023 Cranford, NJ– Steve Brozak, DMH, President of WBB Securities today participated in a Biotech Showcase session titled, Capital Preservation: How to Preserve Capital and Retain Control of Your Research. It was an insightful fireside chat on capital preservation by Charles River Labs. To watch the entire session, please click here… About WBB Securities. WBB Securities is a leading Investment Management, Investment Banking, and Equity Research firm focused primarily in the life sciences niche. Established in 2001 with offices in New Jersey, New York, and California. WBB Securities is registered with the SEC as a broker-dealer, a member of FINRA, and a state-registered investment advisor with a proprietary trading desk. The firm is comprised of a nationwide team of respected senior investment and research professionals serving institutional and high-net-worth clients. www.wbbsec.com  About Biotech Showcase.  Biotech Showcase is the investor and partnering conference for private, small- and mid-cap biotech companies. The event is organized by the EBD Group, which organizes a family of international partnering events to create a dynamic marketplace where thousands of industry professionals meet one-to-one to discuss the in- and out-licensing of assets, strategic collaborations, and financial investment. Each year EBD events generate more than 50,000 one-to-one meetings. www.biotech-showcase.com

  • WBBRI assembled a panel of experts, including its own Director of Medical Research, Dr. Richard A. Marfuggi, to explain not only the physiologic processes of Covid/sepsis but also the critical importance of deployment and adoption of rapid diagnostics and targeted therapeutics

Opinions & Features

View All